Skip to main content
Premium Trial:

Request an Annual Quote

HGS and Affymetrix Will Develop Probe Arrays

Premium

ROCKVILLE, Md.--Human Genome Sciences announced that it will collaborate with Affymetrix to develop certain bacterial GeneChip probe arrays. HGS will contribute proprietary sequence information covering selected bacterial genomes and Affymetrix will have the exclusive right to use the information, based upon these sequences, to design, manufacture, and sell proprietary array products developed through the collaboration.

Filed under

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.